WellPoint Reports Fourth Quarter and Full Year 20...(582.4 593.1 (1.8%) Tot...),Health

Total operating revenue 60,122.0 56,160.4 7.1%

Net investment income 1,001.1 878.7 13.9%

Net realized gains (losses) on

investments 11.2 (0.3) -

Total revenues 61,134.3 57,038.8 7.2%

Expenses

Benefit expense 46,036.1 42,191.4 9.1%

Selling, general and administrative

expense

Selling expense 1,716.8 1,654.5 3.8%

General and administrative

expense 6,984.7 7,163.2 (2.5%)

Total selling, general and

administrative expense 8,701.5 8,817.7 (1.3%)

Cost of drugs 400.2 414.4 (3.4%)

Interest expense 447.9 403.5 11.0%

Amortization of other intangible

assets 290.7 297.4 (2.3%)

Total expenses 55,876.4 52,124.4 7.2%

Income before income tax expense 5,257.9 4,914.4 7.0%

Income tax expense 1,912.5 1,819.5 5.1%

Net income $3,345.4 $3,094.9 8.1%

Net income per diluted share $5.56 $4.82 15.4%

Diluted shares 602.0 642.1 (6.2%)

Benefit expense as a percentage of

premiums 82.4% 81.2% 120 bp

Selling, general and administrative

expense as a percentage of total

operating revenue 14.5% 15.7% (120) bp

Income before income tax expense as a

percentage of total revenues 8.6% 8.6% 0 bp
'/>"/>